Clinical and anthropometric evolution of individuals with cystic fibrosis during COVID‐19 pandemic: A 24‐month cohort study
Pediatric Pulmonology · 2024
DOI: 10.1002/ppul.27027 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pediatric Pulmonology, 2024. Verfasst von Taynara Júlia de Oliveira und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Education on Health, Federal University of Espírito Santo, Vitória, Espírito Santo, Brazil. Hauptthemen laut MEDLINE: Cystic Fibrosis, COVID-19, Body Mass Index. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Objectives
To analyze the evolution of clinical and anthropometric characteristics of children and adolescents with cystic fibrosis (CF) over 24 months, including the period of the COVID‐19 pandemic.
Methods
A longitudinal study with data collection from May 2018 to November 2020 in physical and electronic records from a pediatric reference center, including individuals with CF aged up to 18 years.
Results
The sample encompassed 72 individuals. Weight ( p < 0.01), height ( p < 0.01), and body mass index (BMI) ( p = 0.043) were higher in 2020 than in 2018. There were no significant changes in BMI‐Z ( p = 0.977) and in percentiles of weight ( p = 0.540), height ( p = 0.458), and BMI percentile ( p = 0.454) between both periods. Pancreatic insufficiency was observed in 91.7% of patients in 2020, and there were twice as many confirmed cases of diabetes compared to 2018. There was a 9.7% increase in individuals colonized by the oxacillin‐sensitive Staphylococcus aureus (OSSA) ( p = 0.039) and an 11.1% reduction in non‐colonized individuals ( p = 0.008).
Conclusion
Although there was an increase in weight, height, and BMI from 2018 to 2020, there were no significant changes in BMI‐Z and in percentiles of weight, height, and BMI percentile, suggesting that the anthropometric aspects of nutritional status did not change in this period of 2 years. Moreover, there was an increase in the prevalence of individuals colonized by OSSA and a reduction in the prevalence of individuals non‐colonized with any bacteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Integrated Education on Health, Federal University of Espírito Santo, Vitória, Espírito Santo, Brazil.
- Nossa Senhora da Glória Children's State Hospital, Vitória, Espírito Santo, Brazil.
ORCID-Profile: Flavia Marini Paro
Zitieren
APA
de Oliveira, T. J., Altoé, I. D., Arpini, L. D. S. B., Liberato, F. M. G., Melotti, R. C. N. C., Wittmer, V. L., Duarte, H., Barbalho-Moulim, M. C., & Paro, F. M. (2024). Clinical and anthropometric evolution of individuals with cystic fibrosis during COVID‐19 pandemic: A 24‐month cohort study. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27027
Vancouver
de Oliveira TJ, Altoé ID, Arpini LDSB, Liberato FMG, Melotti RCNC, Wittmer VL, et al. Clinical and anthropometric evolution of individuals with cystic fibrosis during COVID‐19 pandemic: A 24‐month cohort study. Pediatric Pulmonology. 2024. doi:10.1002/ppul.27027
BibTeX
@article{deOliveira2024,
author = {de Oliveira, Taynara Júlia and Altoé, Izabela Dondoni and Arpini, Luana da Silva Baptista and Liberato, Fernanda Mayrink Gonçalves and Melotti, Roberta de Cássia Nunes Cruz and Wittmer, Veronica Lourenço and Duarte, Halina and Barbalho-Moulim, Marcela Cangussu and Paro, Flavia Marini},
title = {Clinical and anthropometric evolution of individuals with cystic fibrosis during COVID‐19 pandemic: A 24‐month cohort study},
journal = {Pediatric Pulmonology},
year = {2024},
doi = {10.1002/ppul.27027}
}
EUVIMED